Cargando…
Pharmacological Small Molecules against Prostate Cancer by Enhancing Function of Death Receptor 5
Death receptor 5 (DR5) is a membrane protein that mediates exogenous apoptosis. Based on its function, it is considered to be a target for the treatment of cancers including prostate cancer. It is encouraging to note that a number of drugs targeting DR5 are now progressing to different stages of cli...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413322/ https://www.ncbi.nlm.nih.gov/pubmed/36015177 http://dx.doi.org/10.3390/ph15081029 |